Patents by Inventor Swapnil Yerande

Swapnil Yerande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230091355
    Abstract: The present invention relates to a process for the preparation of 1-[4-nitro-2-(trifluoromethyl)-phenyl]-alkanones and substituted phenoxyphenyl ketones.
    Type: Application
    Filed: February 2, 2021
    Publication date: March 23, 2023
    Inventors: Timo Frassetto, Florian Vogt, Christiane Alznauer, Sebastian Illies, Philip Muelheims, Swapnil Yerande, Daniel Saelinger, Robin Thiele, Heinz Rriedrich Sutoris, Marcel Hofrichte
  • Publication number: 20220324790
    Abstract: The present invention relates to a process for the preparation of ?-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate and to the ?-methyl-[4-(nitro)-2-(trifluoromethyl)]-benzyl nitrate.
    Type: Application
    Filed: September 2, 2020
    Publication date: October 13, 2022
    Inventors: Timo Frassetto, Florian Vogt, Swapnil Yerande, Christiane Alznauer, Sebastian Illies, Philip Muelheims, Daniel Saelinger, Robin Thiele, Heinz Friedrich Sutoris
  • Patent number: 8981121
    Abstract: The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: March 17, 2015
    Assignee: UCB Pharma GmbH
    Inventors: Celal Ates, Arnaud Schule, Magali Palacio, Paul Deutsch, David Vasselin, Nicolas Carly, Ganesh Phadtare, Swapnil Yerande, Jean-Pierre Delatinne, Maria Luisa Escudero Hernandez, Veronique Pinilla
  • Publication number: 20130102794
    Abstract: The present invention provides an alternative synthesis of N-substituted aminotetralines comprising resolution of N-substituted aminotetralins of formula (II), wherein R1, R2 and R3 are as defined for compound of formula (I).
    Type: Application
    Filed: June 24, 2011
    Publication date: April 25, 2013
    Applicant: UCB PHARMA GMBH
    Inventors: Celal Ates, Arnaud Schule, Magali Palacio, Paul Deutsch, David Vasselin, Nicolas Carly, Ganesh Phadtare, Swapnil Yerande, Jean-Pierre Delatinne, Maria Luisa Escudero Hernandez, Veronique Pinilla